CGEM icon

Cullinan Oncology
CGEM

Overview Fund Activity

113 hedge funds and large institutions have $671M invested in Cullinan Oncology in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
40
Reduced
38
Closed
18
Calls
$215K
Puts
$158K
Net Calls
+$57K
Net Calls Change
+$70K

Top Buyers

1
PBA
Paradigm Biocapital Advisors
New York
$23M
2
DM
Deerfield Management
New York
$19.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
$16.2M
4
State Street
State Street
Massachusetts
$24.3M
5
LGM
Logos Global Management
California
$11.9M

Top Sellers

1
AIG
American International Group
New York
$217K
2
Morgan Stanley
Morgan Stanley
New York
$19.6M
3
Franklin Resources
Franklin Resources
California
$46M
4
BOCH
Blue Owl Capital Holdings
New York
$49.8M
5
PHP
Parkman Healthcare Partners
Connecticut
$3.04M
Name Holding Trade Value Shares
Change 		Shares
Change %
GCP
126
GSA Capital Partners
United Kingdom
– -$104K -10,246 Closed
VOYA Investment Management
127
VOYA Investment Management
Georgia
– -$103K -10,061 Closed
Vontobel Holding
128
Vontobel Holding
Switzerland
– -$102K -10,000 Closed
PAS
129
Point72 Asia (Singapore)
Singapore
– -$29.1K -2,852 Closed
Russell Investments Group
130
Russell Investments Group
United Kingdom
– -$23.4K -2,300 Closed
PMEF
131
Point72 Middle East FZE
United Arab Emirates
– -$12.2K -1,195 Closed
2 3 4 5
6